Guide | Early Pregnancy Tests: What Every Expectant Mother Should Know
For many expectant mothers, pregnancy begins a new chapter and a much closer relationship with medical care. Women who previously had only occasional checkups, blood tests, or Pap smears will now undergo a series of prenatal tests closely related to fetal health.
Although there are many types of tests, most provide important health information about the pregnant woman and fetus. Some screen for nutritional or metabolic conditions such as iron-deficiency anemia or gestational diabetes, allowing timely intervention to prevent serious complications. Others assess the fetus for chromosomal or genetic conditions such as Down syndrome, cystic fibrosis, or spina bifida, which may require difficult decisions and emotional preparation from expectant parents.
“Not all of these tests are definitive,” said Dr. Michael Mennuti, chair of obstetrics and gynecology at the University of Pennsylvania School of Medicine. “Initial screening identifies people at high risk who may need further diagnostic testing, which can carry some risk to the fetus.” He also emphasized that most babies are healthy, with congenital genetic defects affecting only about 2% to 3% of newborns.
Dr. Mennuti advises expectant mothers and their partners to understand each test’s purpose, accuracy, risks, and options following an unfavorable result before deciding. “If a couple would not change their decision about the pregnancy regardless of the result, invasive diagnostic tests such as amniocentesis or chorionic villus sampling may not be necessary. If they would consider ending the pregnancy, or simply want to prepare for a child with special needs, these tests become particularly important.”
Common prenatal tests during the first trimester (weeks 1 to 12) include:
Blood tests
At the first prenatal visit, a physician or midwife will use blood tests to determine your blood type and Rh factor, assess iron levels, check immunity to rubella (German measles), and screen for hepatitis B, syphilis, and HIV.
If the pregnant woman belongs to certain ethnic groups or has a relevant family history, the physician may also recommend genetic screening and counseling for conditions such as Tay-Sachs disease, Canavan disease, cystic fibrosis, thalassemia, and sickle cell anemia. These tests can also be completed before conception.
Urine tests
In early pregnancy, a urine sample may be collected to check for kidney infection and confirm pregnancy by measuring human chorionic gonadotropin (hCG). Urine testing is repeated at later prenatal visits to monitor abnormal glucose, a sign of diabetes, or albumin, a possible sign of pregnancy-related hypertension.
Pap smear and vaginal swabs
A Pap smear is commonly performed early in pregnancy to screen for cervical cancer. Vaginal swabs may also screen for infections such as chlamydia, gonorrhea, and bacterial vaginosis, which are associated with preterm birth. Prompt treatment can significantly reduce risks to the newborn.
Chorionic villus sampling (CVS)
For pregnant women over 35 or those with a serious family history of genetic disease, physicians often recommend chorionic villus sampling between weeks 10 and 12. With about 99% accuracy, CVS can detect Down syndrome, cystic fibrosis, hemophilia, Huntington’s disease, muscular dystrophy, and many other genetic disorders.
The procedure obtains placental tissue through a catheter inserted via the cervix or a needle passed through the abdomen. It carries an approximately 1% risk of miscarriage and cannot detect open neural tube defects such as spina bifida or anencephaly.
New Down syndrome screening: combined blood test and ultrasound
A newer noninvasive method is also becoming more common. Between weeks 10 and 14, maternal blood levels of hCG and pregnancy-associated plasma protein A (PAPP-A) are combined with ultrasound measurement of fetal nuchal translucency (NT) to screen early for Down syndrome risk.
“This combined screening can identify a substantial proportion of Down syndrome and other chromosomal abnormalities,” said Dr. John Larsen, professor of obstetrics, gynecology, and genetics at George Washington University. A positive screen still requires confirmation with a more definitive test such as CVS.
Pregnancy can involve difficult, practical decisions as well as excitement and anticipation. A systematic, evidence-based testing process gives expectant parents more opportunity to address potential concerns early and protect their baby’s health.
Guide | Early Pregnancy Tests: What Every Expectant Mother Should Know
Guide | Early Pregnancy Tests: What Every Expectant Mother Should Know
For many expectant mothers, pregnancy begins a new chapter and a much closer relationship with medical care. Women who previously had only occasional checkups, blood tests, or Pap smears will now undergo a series of prenatal tests closely related to fetal health.
Although there are many types of tests, most provide important health information about the pregnant woman and fetus. Some screen for nutritional or metabolic conditions such as iron-deficiency anemia or gestational diabetes, allowing timely intervention to prevent serious complications. Others assess the fetus for chromosomal or genetic conditions such as Down syndrome, cystic fibrosis, or spina bifida, which may require difficult decisions and emotional preparation from expectant parents.
“Not all of these tests are definitive,” said Dr. Michael Mennuti, chair of obstetrics and gynecology at the University of Pennsylvania School of Medicine. “Initial screening identifies people at high risk who may need further diagnostic testing, which can carry some risk to the fetus.” He also emphasized that most babies are healthy, with congenital genetic defects affecting only about 2% to 3% of newborns.
Dr. Mennuti advises expectant mothers and their partners to understand each test’s purpose, accuracy, risks, and options following an unfavorable result before deciding. “If a couple would not change their decision about the pregnancy regardless of the result, invasive diagnostic tests such as amniocentesis or chorionic villus sampling may not be necessary. If they would consider ending the pregnancy, or simply want to prepare for a child with special needs, these tests become particularly important.”
Common prenatal tests during the first trimester (weeks 1 to 12) include:
Blood tests
At the first prenatal visit, a physician or midwife will use blood tests to determine your blood type and Rh factor, assess iron levels, check immunity to rubella (German measles), and screen for hepatitis B, syphilis, and HIV.
If the pregnant woman belongs to certain ethnic groups or has a relevant family history, the physician may also recommend genetic screening and counseling for conditions such as Tay-Sachs disease, Canavan disease, cystic fibrosis, thalassemia, and sickle cell anemia. These tests can also be completed before conception.
Urine tests
In early pregnancy, a urine sample may be collected to check for kidney infection and confirm pregnancy by measuring human chorionic gonadotropin (hCG). Urine testing is repeated at later prenatal visits to monitor abnormal glucose, a sign of diabetes, or albumin, a possible sign of pregnancy-related hypertension.
Pap smear and vaginal swabs
A Pap smear is commonly performed early in pregnancy to screen for cervical cancer. Vaginal swabs may also screen for infections such as chlamydia, gonorrhea, and bacterial vaginosis, which are associated with preterm birth. Prompt treatment can significantly reduce risks to the newborn.
Chorionic villus sampling (CVS)
For pregnant women over 35 or those with a serious family history of genetic disease, physicians often recommend chorionic villus sampling between weeks 10 and 12. With about 99% accuracy, CVS can detect Down syndrome, cystic fibrosis, hemophilia, Huntington’s disease, muscular dystrophy, and many other genetic disorders.
The procedure obtains placental tissue through a catheter inserted via the cervix or a needle passed through the abdomen. It carries an approximately 1% risk of miscarriage and cannot detect open neural tube defects such as spina bifida or anencephaly.
New Down syndrome screening: combined blood test and ultrasound
A newer noninvasive method is also becoming more common. Between weeks 10 and 14, maternal blood levels of hCG and pregnancy-associated plasma protein A (PAPP-A) are combined with ultrasound measurement of fetal nuchal translucency (NT) to screen early for Down syndrome risk.
“This combined screening can identify a substantial proportion of Down syndrome and other chromosomal abnormalities,” said Dr. John Larsen, professor of obstetrics, gynecology, and genetics at George Washington University. A positive screen still requires confirmation with a more definitive test such as CVS.
Pregnancy can involve difficult, practical decisions as well as excitement and anticipation. A systematic, evidence-based testing process gives expectant parents more opportunity to address potential concerns early and protect their baby’s health.
Source:
Collected online